License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Phase 3 Randomized Double-Blind Placebo-Controlled Multinational Clinical Study to Evaluate the Efficacy and Safety of 20 mgkgweek and 20 mgkgevery other week BMN 110 in Patients with Mucopolysaccharidosis IVA Morquio A Syndrome

To evaluate the ability of 20 mgkgweek BMN 110 and 20 mgkgqow BMN 110 compared with placebo to enhance endurance in patients with MPS IVA as measured by an increase in the number of meters walked in the 6-minute walk 6MW test from baseline to Week 24

FieldValue
Modified
2019-11-12
Release Date
2019-04-30
Identifier
04e94c6b-590f-4bcd-b4e1-d04677113075
License
License Not Specified
Public Access Level
Public